4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-20-008833
EVP/Chief Scientific Officer sold 10,238 shares at an average $37.41 ($383,028)
- EVP/Chief Scientific Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Albright Charles · EVP/Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-06 | Exercise or conversion : show line 1 in the form | +10,000 | $16.51 | $165,100 | 38,373 | D |
| 2020-08-06 | Sale : show line 2 in the form | −10,000 | $37.47 | $374,700 | 28,373 | D |
| 2020-08-07 | Sale : show line 3 in the form | −238 | $34.99 | $8,328 | 28,135 | D |
| Open-market sales · 10,238 sh · avg $37.41 · $383,028 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-08-06 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −10,000 | 195,000 | D |
Loading xslF345X03/edgar.xml…